Mechanistically, lipid profile amelioration in T2D by VLCKD could be ascribed to the above-described actions of acetoacetate via GPR43 (56) and of β-OHB via GPR109A on lipolysis (46, 51) and to the insulin resistance amelioration. Here, HCAR2 is linked to Insulin resistance.